FDA Shortages September/October 2021
You are subscribed to Drug Shortages for U.S. Food and Drug Administration. This information has recently been updated, and is now available.
Atropine Sulfate Ophthalmic Ointment (Updated - Resolved)
Bupivacaine Hydrochloride Injection (Updated - Currently in Shortage)
Chlordiazepoxide Hydrochloride Capsules (Updated - Currently in Shortage)
Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
Dexmedetomidine Injection (Updated - Currently in Shortage)
Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)
Famotidine Tablets (Updated - Currently in Shortage)
Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)
Histreline Acetate Implant (New - Discontinuation)
Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)
Ketamine Injection (Updated - Currently in Shortage)
Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
Loxapine Capsules (Updated - Currently in Shortage)
Nefazodone Hydrochloride Tablets (Updated - Currently in Shortage)
Nizatidine Capsules (Updated - Currently in Shortage)
Propofol Injectable Emulsion (Updated - Currently in Shortage)
Sulfasalazine Tablets (Updated - Currently in Shortage)
Vecuronium Bromide for Injection (Updated - Currently in Shortage)
Dobutamine Hydrochloride Injection (Updated - Currently in Shortage)
Dopamine Hydrochloride Injection (Updated - Currently in Shortage)
Heparin Sodium and Sodium Chloride 0.9% Injection (Updated - Currently in Shortage)
Mannitol Injection (New - Currently in Shortage)
